title: The inherent metastasis of leukaemia and its exploitation by sonodynamic therapy.
abstract: Nearly all cancers are linked by the inexorable phenotype of metastasis as malignant growths have the capability to spread from their place of origin to distant sites throughout the body. While different cancers may have various propensities to migrate towards specific locations, they are all linked by this unifying principal. Unlike most neoplasms, leukaemia has inherent cell motility as leukocytes are required to move throughout the vascular system, suggesting that no mutations are required for anchorage independent growth. As such, it seems likely that leukaemias are inherently metastatic, endowed with the deadliest phenotype of cancer simply due to cell of origin. This article presents the biology of metastasis development and how leukaemia cells are inherently provided these phenotypic characteristics. It is then proposed how clinicians may be able to exploit the motility of leukaemia and metastatic emboli of other cancer types through an approach known as sonodynamic therapy (SDT), a treatment modality that combines chemotherapeutic agents with ultrasound to preferentially damage malignant cells. As experimental evidence has indicated, SDT is a promising therapeutic approach in need of clinical testing for further validation.
authors.affiliation: Department of Biology, Syracuse University, 107 College Place, Syracuse, NY 13244, USA. Electronic address: mrtrendo@syr.edu.
authors.forename: Matthew
authors.initials: M
authors.lastname: Trendowski
mesh_terms: D000818:Animals; D006801:Humans; D007938:Leukemia / Q000209:etiology / Q000473:pathology* / Q000628:therapy*; D009362:Neoplasm Metastasis; D014464:Ultrasonic Therapy / Q000379:methods
keywords: Chemotherapy; Drug resistance; Leukaemia; Leukocytes; Metastasis; Sonodynamic therapy; Ultrasound